Monograph
J07AP01 - Typhoid, Oral, Live Attenuated |
Propably not porphyrinogenic |
PNP |
Side effects
Common adverse reactions of the oral typhoid vaccine that can be confused with an acute porphyric attack are abdominal pain, nausea, diarrhoea, vomiting. These side effects may potentially be porphyrinogenic if leading to a decrease in carbohydrate intake.
Also fever and influenza-like illness are common side effects of the vaccine and it is possible that this can trigger an acute porphyric attack in the same way as infections are known to.
Rationale
Based on the pharmacokinetics of the typhoid, oral, live attenuated vaccine, there are no conceivable porphyrinogenic effects.
Chemical description
Live attenuated salmonella enterica serovar Typhi.
Therapeutic characteristics
For active immunization against typhoid fever in children aged 6 years and over, adults and elderly.
The vaccine is administered orally, in form of three capsules taken over five days.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Government bodies | |
| 1. | Norwegian Institute of Public Health. Vaksinasjonsveilederen. www.fhi.no (updated 13.10.2015).
|
|
| * | Summary of Product Characteristics | |
| 2. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Vivotif. (Last edition: 31.03 2015).
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Vivotif 
Vivotif gél. gastro-résist. 
Vivotif 
Vivotif vaccine 
Vivotif 
Vivotif 
Vivotif 
Vivotif 
Vivotif
© NAPOS 2025